NeueHealth (NYSE:NEUE) Director Sells $24,536.25 in Stock

Key Points

• Rick Yang, a director at NeueHealth, sold 3,635 shares at an average price of $6.75, totaling $24,536.25, resulting in a 0.74% decrease in his ownership of the stock.
• NeueHealth reported an EPS of ($1.68) for the last quarter, exceeding expectations but missing revenue forecasts with $209.08 million against the anticipated $249.50 million.
• Analysts have a consensus rating of "Reduce" for NeueHealth, with an average target price of $7.00, highlighting a cautious outlook for the stock's performance.

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) Director Rick Yang sold 3,635 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total transaction of $24,536.25. Following the completion of the transaction, the director owned 488,702 shares of the company's stock, valued at approximately $3,298,738.50. The trade was a 0.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

NeueHealth Stock Performance

Shares of NYSE:NEUE remained flat at $6.75 during midday trading on Monday. NeueHealth, Inc. has a 1-year low of $3.79 and a 1-year high of $7.66. The firm has a market capitalization of $60.94 million, a price-to-earnings ratio of -0.42 and a beta of 0.59. The stock's 50-day moving average price is $6.72 and its 200 day moving average price is $6.72.

NeueHealth (NYSE:NEUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, topping the consensus estimate of ($4.77) by $3.09. The company had revenue of $209.08 million during the quarter, compared to analysts' expectations of $249.50 million. Sell-side analysts forecast that NeueHealth, Inc. will post -9.13 EPS for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of NeueHealth in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, NeueHealth currently has an average rating of "Reduce" and an average target price of $7.00.

Hedge Funds Weigh In On NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. acquired a new position in shares of NeueHealth, Inc. (NYSE:NEUE - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 29,115 shares of the company's stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned 0.33% of NeueHealth as of its most recent filing with the Securities & Exchange Commission. 63.88% of the stock is owned by hedge funds and other institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.